You just read:

Prometheus Diagnostic Test Validated in Anticipation of U.S. Healthcare Provider Demand for Celltrion's INFLECTRA™ (Biosimilar Infliximab)

News provided by

Prometheus Laboratories Inc.

07 Apr, 2016, 16:30 ET